1. Sagae T, Yokogawa M, Sawazaki R, Ishii Y, Hosoda N, Hoshino SI, Imai S, Shimada I, Osawa M. Paip2A inhibits translation by competitively binding to the RNA recognition motifs of PABPC1 and promoting its dissociation from the poly(A) tail, Journal of Biological Chemistry, 2022, 298, 101844, doi:10.1016/j.jbc.2022.101844.
2. Shimizu Y, Yonezawa T, Sakamoto J, Furuya T, Osawa M, Ikeda K. Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning. Scientific Reports, 2021, 11, 7420, doi:10.1038/s41598-021-86616-1.
3. Michalak M, Lach MS, Borska S, Nowakowski B, Umezawa K, Suchorska WM. DHMEQ enhances the cytotoxic effect of cisplatin and carboplatin in ovarian cancer cell lines. American Journal of Cancer Research. 2021, 11, 6024-6041.
4. Fujisaki H, Nakano Y, Matsuda S, Suzuki K, Itano O, Tanaka M, Hori S, Hasegawa Y, Abe Y, Yagi H, Kitago M, Konno T, Ishihara K, Ohno K, Kishino S, Umezawa K, Kitagawa Y. Intravenous Administration of Dehydroxymethylepoxyquinomicin With Polymer Enhances the Inhibition of Pancreatic Carcinoma Growth in Mice. Anticancer Research. 2021, 41, 6003-6012, doi:10.21873/anticanres.15419.
5. Lin Y, Sidthipong K, Ma J, Koide N, Umezawa K, Kubota T. Designed NF-κB inhibitor, DHMEQ, inhibits KISS1R-mediated invasion and increases drug-sensitivity in mouse plasmacytoma SP2/0 cells. Experimental and Therapeutic Medicine. 2021, 22, 1092, doi:10.3892/etm.2021.10526.
6. Ma J, Zhang Y, Sugai T, Kubota T, Keino H, El-Salhy M, Ozaki M, Umezawa K. Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ. Cells. 2021, 10, 2271, doi:10.3390/cells10092271.
7. Ikeda K, Kezuka Y, Nonaka T, Yonezawa T, Osawa M, Katoh E. Comprehensive Approach of 19F Nuclear Magnetic Resonance, Enzymatic, and In Silico Methods for Site-Specific Hit Selection and Validation of Fragment Molecules that Inhibit Methionine γ-Lyase Activity. Journal of Medicinal Chemistry. 2021, 64, 14299-14310, doi:10.1021/acs.jmedchem.1c00766.
8. Matsumura K, Yokogawa M, Osawa M. Peptide Toxins Targeting KV Channels. Handbook of Experimental Pharmacology. 2021, 267, 481-505, doi:10.1007/164_2021_500.
9. Nakade Y, Kitano R, Yamauchi T, Kimoto S, Sakamoto K, Inoue T, Kobayashi Y, Ohashi T, Sumida Y, Ito K, Yoneda M. Effect of Central Corticotropin-Releasing Factor on Hepatic Lipid Metabolism and Inflammation-Related Gene Expression in Rats. International Journal of Molecular Sciences. 2021, 22, 3940. doi:10.3390/ijms22083940.
10. 伊藤清顕, ステロイドや免疫抑制薬使用中のde novo B型肝炎予防と発症後の対処 いまさら聞けない!肝胆膵疾患, medicina. 2021, 58, 410-414, doi:10.11477/mf.1402227463.